Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity
作者:Vadim A. Shiryaev、Michael Yu Skomorohov、Marina V. Leonova、Nikolai I. Bormotov、Olga A. Serova、Larisa N. Shishkina、Alexander P. Agafonov、Rinat A. Maksyutov、Yuri N. Klimochkin
DOI:10.1016/j.ejmech.2021.113485
日期:2021.10
One of the potential targets of poxviruses is the p37 protein, which is a tecovirimat target. This protein is relatively small, has no homologs among proteins of humans and other mammals and is necessary for the replication of viral particles, which makes it attractive target for virtual screening. Using the I-TASSER modelling and molecular dynamics refinement the p37 orthopox virus protein model was
2-Adamantyl hydrazines and pharmaceutical compositions containing them
申请人:Teva Pharmaceutical Industries Limited
公开号:EP0002066A1
公开(公告)日:1979-05-30
The invention provides novel 2-adamantyl hydrazine derivatives of the general formula A
In this formula R, is hydrogen or a lower alkyl group of 1-4 carbon atoms; R2 and R3 are the same or different and are each hydrogen, an unsubstituted or substituted radical being a lower alkyl of 1-4 carbon atoms, a lower alkanoic acid radical of 2-4 carbon atoms or a lower alkyl ester thereof, adamantyl, aryl, aralkyl, in which the alkyl moiety has from 1-4 carbon atoms or an unsubstituted or substituted heterocyclic radical of aromatic character; or R2 and R3 together with the nitrogen atom to which they are attached form an unsubstituted or substituted non-aromatic cyclic radical.
The invention further provides pharmaceutically acceptable acid addition salts of the above compounds.
Several methods of preparation of the new compounds are described.
The novel compounds according to the invention possess valuable antifungal (human and plant), antiviral, antiprotozoal and antimicrobial properties.